Neuropace
NPCE
NPCE
28 hedge funds and large institutions have $53.1M invested in Neuropace in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $71.4M → $53.1M (-$18.3M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$519K | |
| 2 | +$294K | |
| 3 | +$116K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$98.3K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$38K |
Top Sellers
| 1 | -$769K | |
| 2 | -$665K | |
| 3 | -$448K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$131K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$108K |